METTL2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.557200E-01
Normal-vs-Stage2
3.417800E-01
Normal-vs-Stage3
9.743000E-01
Normal-vs-Stage4
8.495800E-02
Stage1-vs-Stage2
1.826450E-01
Stage1-vs-Stage3
5.023800E-01
Stage1-vs-Stage4
4.929600E-01
Stage2-vs-Stage3
2.597200E-01
Stage2-vs-Stage4
8.572800E-01
Stage3-vs-Stage4
4.086200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.350600E-01
Normal-vs-AfricanAmerican
1.781040E-01
Normal-vs-Asian
3.054800E-01
Caucasian-vs-AfricanAmerican
3.108800E-01
Caucasian-vs-Asian
2.559800E-01
AfricanAmerican-vs-Asian
4.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.242400E-01
Normal-vs-Female
3.579000E-01
Male-vs-Female
6.487800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.669450E-01
Normal-vs-Age(41-60Yrs)
1.123380E-01
Normal-vs-Age(61-80Yrs)
4.693800E-01
Normal-vs-Age(81-100Yrs)
4.194800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.82930000000026E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.405700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.064600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.480400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.781200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.627400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.039000E-01
Normal-vs-Daily Drinker
7.428400E-01
Normal-vs-Weekly Drinker
4.383600E-01
Normal-vs-Occasional Drinker
2.071600E-01
Normal-vs-Social Drinker
6.362200E-02
Non Drinker-vs-Daily Drinker
5.999400E-01
Non Drinker-vs-Weekly Drinker
4.043800E-01
Non Drinker-vs-Occasional Drinker
1.473590E-01
Non Drinker-vs-Social Drinker
2.086400E-02
Daily Drinker-vs-Weekly Drinker
2.232800E-01
Daily Drinker-vs-Occasional Drinker
5.196200E-02
Daily Drinker-vs-Social Drinker
4.676800E-03
Weekly Drinker-vs-Occasional Drinker
7.373000E-01
Weekly Drinker-vs-Social Drinker
2.974600E-01
Occasional Drinker-vs-Social Drinker
3.641200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.745550E-01
Normal-vs-Grade 2
1.724570E-01
Normal-vs-Grade 3
4.875800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.894800E-01
Grade 1-vs-Grade 3
1.857010E-01
Grade 1-vs-Grade 4
1.745550E-01
Grade 2-vs-Grade 3
3.670000E-01
Grade 2-vs-Grade 4
1.724570E-01
Grade 3-vs-Grade 4
4.875800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.310400E-01
Normal-vs-NonDiabetic
3.263000E-01
Diabetic-vs-NonDiabetic
1.291560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.672000E-01
Normal-vs-NoPancreatitis
3.957000E-01
Pancreatitis-vs-NoPancreatitis
4.449000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.666200E-01
Normal-vs-N1
3.080400E-01
N0-vs-N1
4.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.675380E-03
Normal-vs-TP53-NonMutant
2.961200E-03
TP53-Mutant-vs-TP53-NonMutant
7.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
